» Articles » PMID: 38388186

Differences in Serum MiRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test

Abstract

Prevention Relevance: This study aimed to understand factors affecting miRNA expression, to ensure we create equitable screening tests for ovarian cancer that perform well in diverse populations. The goal is to ensure that we are detecting ovarian cancer cases earlier (secondary prevention) in women of all races, ethnic backgrounds, and socioeconomic means.

Citing Articles

Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case report.

Kimura T, Sakata K, Ohga N, Sato J, Itagaki T, Munekata T Oncol Lett. 2024; 29(1):52.

PMID: 39564374 PMC: 11574702. DOI: 10.3892/ol.2024.14798.


MicroRNA expression alteration in chronic thromboembolic pulmonary hypertension: A systematic review.

Sulastomo H, Dinarti L, Hariawan H, Haryana S Pulm Circ. 2024; 14(3):e12443.

PMID: 39308943 PMC: 11413763. DOI: 10.1002/pul2.12443.

References
1.
Nwanaji-Enwerem J, Jackson C, Ann Ottinger M, Cardenas A, James K, Malecki K . Adopting a "Compound" Exposome Approach in Environmental Aging Biomarker Research: A Call to Action for Advancing Racial Health Equity. Environ Health Perspect. 2021; 129(4):45001. PMC: 8043128. DOI: 10.1289/EHP8392. View

2.
Elias K, Fendler W, Stawiski K, Fiascone S, Vitonis A, Berkowitz R . Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife. 2017; 6. PMC: 5679755. DOI: 10.7554/eLife.28932. View

3.
Ghafouri-Fard S, Shoorei H, Taheri M . miRNA profile in ovarian cancer. Exp Mol Pathol. 2020; 113:104381. DOI: 10.1016/j.yexmp.2020.104381. View

4.
Straumfors A, Duale N, Foss O, Mollerup S . Circulating miRNAs as molecular markers of occupational grain dust exposure. Sci Rep. 2020; 10(1):11317. PMC: 7347934. DOI: 10.1038/s41598-020-68296-5. View

5.
Sasamoto N, Babic A, Rosner B, Fortner R, Vitonis A, Yamamoto H . Predicting Circulating CA125 Levels among Healthy Premenopausal Women. Cancer Epidemiol Biomarkers Prev. 2019; 28(6):1076-1085. PMC: 6548604. DOI: 10.1158/1055-9965.EPI-18-1120. View